Skip to main content
Log in

Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

An objective of the present investigation was to prepare and evaluate Eudragit-coated pectin microspheres for colon targeting of 5-fluorouracil (FU). Pectin microspheres were prepared by emulsion dehydration method using different ratios of FU and pectin (1:3 to 1:6), stirring speeds (500–2000 rpm) and emulsifier concentrations (0.75%–1.5% wt/vol). The yield of preparation and the encapsulation efficiencies were high for all pectin microspheres. Microspheres prepared by using drug:polymer ratio 1:4, stirring speed 1000 rpm, and 1.25% wt/vol concentration of emulsifying agent were selected as an optimized formulation. Eudragit-coating of pectin microspheres was performed by oil-in-oil solvent evaporation method using coat: core ratio (5:1). Pectin microspheres and Eudragit-coated pectin microspheres were evaluated for surface morphology, particle size and size distribution, swellability, percentage drug entrapment, and in vitro drug release in simulated gastrointestinal fluids (SGF). The in vitro drug release study of optimized formulation was also performed in simulated colonic fluid in the presence of 2% rat cecal content. Organ distribution study in albino rats was performed to establish the targeting potential of optimized formulation in the colon. The release profile of FU from Eudragit-coated pectin microspheres was pH dependent. In acidic medium, the release rate was much slower; however, the drug was released quickly at pH 7.4. It is concluded from the present investigation that Eudragit-coated pectin microspheres are promising controlled release carriers for colon-targeted delivery of FU.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Riley SA, Turnberg LA. Sulphasalazine and aminosalicylate in the treatment of inflammatory bowl disease.Q J Med. 1990;75: 561–562.

    Google Scholar 

  2. Bartalsky A. Salicylazobenzoic acid in ulcerative colitis.Lancet. 1982;319:960–964.

    Article  Google Scholar 

  3. Ashford M, Fell J, Attwood D, Sharma H, Woodhead P. In vitro investigation into the suitability of pH dependent polymer for colonic targeting.Int J Pharm 1993;95:193–199.

    Article  CAS  Google Scholar 

  4. Marvola M, Nykanen P, Rautio S, Isonen N, Autere AM. Enteric polymer as binder and coating material in multiple unit site-specific drug delivery systems.Eur J Pharm Sci. 1999;7:259–267.

    Article  CAS  Google Scholar 

  5. Gazzaniga A, Busetti C, Sangali ME, Giordana ME. Time-dependent oral delivery system for colonic targeting system for the colon targeting.STP Pharma Sci. 1995;5:83–88.

    CAS  Google Scholar 

  6. Gazzaniga A, Iamartino P, Maffione G, Sangal ME. Oral delayed release system system for colonic specific delivery.Int J Pharm. 1994;108:77–83.

    Article  CAS  Google Scholar 

  7. Hovgaard L, Brondsted H. Dextran hydrogels for colon-specific drug delivery.J Control Release. 1995;36:159–166.

    Article  CAS  Google Scholar 

  8. Watts PJ, Lllum L. Colonic drug delivery.Drug Dev Ind Pharm. 1997;23:893–913.

    Article  CAS  Google Scholar 

  9. Ashford M, Fell T. Targeting drugs to colon: delivery system for oral administration.J Drug Target. 1994;2:241–258.

    Article  CAS  Google Scholar 

  10. Kudela V. Hydrogels. In: Mark HF, Bikales N, Overberger CG, Menges G, Kroschwitz JI, eds.Encyclopedia of Polymer Science and Engineering. vol. 7. New York, NY: John Wiley & Sons; 1987:703–807.

    Google Scholar 

  11. Graham NB, McNeill ME. Hydrogels for controlled drug delivery.Biomaterials. 1984;5:27–36.

    Article  CAS  Google Scholar 

  12. Tiwari SB, Murthy TK, Pai MR, Mehta PR, Chowdary PB. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system.AAPS PharmSciTech. 2003;4:E31.

    Article  Google Scholar 

  13. Krusteva S, Lambov N, Velinov G. Pharmaceutical investigation of a bioerodible nystatin system.Pharmazie. 1990;45:195–197.

    CAS  Google Scholar 

  14. Naggar VF, El-Khawas M, Ismail FA, Boraie NA. Pectin, a possible matrix for oral sustained release preparations of water-soluble drugs.STP Pharma Sci. 1992;2:227–234.

    CAS  Google Scholar 

  15. Rubinstein A, Radai R, Ezra M, Pathak S, Rokem JM. In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier.Pharm Res. 1993;10:258–263.

    Article  CAS  Google Scholar 

  16. Esposito E, Cortesi R, Luca G, Nastruzzi C. Pectin based microspheres: a preformulatory study.Ann N Y Acad Sci. 2001;944: 160–179.

    Article  CAS  Google Scholar 

  17. Lorenzo-Lamosa ML, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Design of microen capsulated chitosan microspheres for colonic drug delivery.J Control Release. 1998;52:109–118.

    Article  CAS  Google Scholar 

  18. Indian Pharmacopoeia.Disintegration and Dissolution. Delhi, India: Controller of Publication-Ministry of Health and Family Welfare; 1996:

  19. Rai G, Jain SK, Agrawal S, Pancholi SS, Agrawal GP. Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.Pharmazie. 2005;60:131–134.

    CAS  Google Scholar 

  20. Van den Mooter G, Samyn C, Kinget R. The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery.Pharm Res. 1994;11:1737–1741.

    Article  Google Scholar 

  21. Pongpaibul Y, Price JC, Whitworth CW. Preparation and evaluation of controlled release indomethacin microspheres.Drug Dev Ind Pharm. 1984;410:1597–1616.

    Article  Google Scholar 

  22. Maia JL, Santana MHA, Re MI. The effect of some proceessing conditions on the characteristics of biodegradable microspheres obtained by an emulsion solvent evaporation process.Braz J Chem Eng. 2004;21:1–12.

    Article  CAS  Google Scholar 

  23. Yang Q, Owusu-Ababio G. Biodegradable progesterone microsphere delivery system for osteoporosis therapy.Drug Dev Ind Pharm. 2000;26:61–70.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Govind P. Agrawal.

Additional information

Published: February 16, 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paharia, A., Yadav, A.K., Rai, G. et al. Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS PharmSciTech 8, 12 (2007). https://doi.org/10.1208/pt0801012

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt0801012

KeyWords

Navigation